National Research (NASDAQ:NRC) Announces Earnings Results

National Research (NASDAQ:NRC) announced its earnings results on Tuesday. The company reported $0.16 earnings per share for the quarter, FiscalAI reports. National Research had a return on equity of 98.26% and a net margin of 11.76%.The firm had revenue of $35.19 million during the quarter.

National Research Stock Performance

NRC stock opened at $21.90 on Tuesday. The company has a 50 day moving average price of $19.00 and a 200 day moving average price of $15.88. The stock has a market capitalization of $496.25 million, a PE ratio of 31.29 and a beta of 0.49. National Research has a fifty-two week low of $9.76 and a fifty-two week high of $22.79. The company has a debt-to-equity ratio of 5.31, a current ratio of 0.53 and a quick ratio of 0.53.

Institutional Investors Weigh In On National Research

Several hedge funds have recently bought and sold shares of NRC. Russell Investments Group Ltd. grew its stake in shares of National Research by 85.6% during the 3rd quarter. Russell Investments Group Ltd. now owns 1,997 shares of the company’s stock worth $26,000 after acquiring an additional 921 shares in the last quarter. EverSource Wealth Advisors LLC increased its holdings in shares of National Research by 9,535.3% in the second quarter. EverSource Wealth Advisors LLC now owns 1,638 shares of the company’s stock valued at $28,000 after purchasing an additional 1,621 shares during the last quarter. BNP Paribas Financial Markets raised its holdings in National Research by 85.4% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,496 shares of the company’s stock valued at $32,000 after acquiring an additional 1,150 shares during the period. Strs Ohio acquired a new position in National Research in the 1st quarter valued at $33,000. Finally, Raymond James Financial Inc. acquired a new stake in National Research in the 2nd quarter worth about $34,000. 47.26% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Weiss Ratings cut National Research from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, January 28th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has an average rating of “Sell”.

National Research Company Profile

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.